Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rinderpest virus (RPV) is a highly contagious, single-stranded, negative-sense RNA virus belonging to the genus Morbillivirus within the family Paramyxoviridae (Baron et al., 2011). It was the causative agent of rinderpest, a devastating disease of cattle and other artiodactyls characterized by high fever, necrotic stomatitis, and severe diarrhea, often leading to mortality rates exceeding 90% (Roeder et al., 2013). The virus enters host cells by utilizing its hemagglutinin (H) and fusion (F) glycoproteins to bind to receptors such as the signaling lymphocytic activation molecule (SLAM/CD150) and nectin-4 (Baron, 2021). While RPV is a pathogen rather than a specific therapeutic target, its proteins were the focus of the Plowright vaccine, a live-attenuated tissue culture vaccine that was instrumental in the global eradication effort (Plowright & Ferris, 1962). In 2011, the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) officially declared rinderpest eradicated, making it the first animal disease and the second disease in history to be eliminated by human intervention (WOAH, 2011).
Vaccines induce neutralizing antibodies against viral surface glycoproteins (Hemagglutinin and Fusion proteins) to block viral attachment and entry into host cells.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rinderpest virus (RPV) (RPV).